PeptidePedia The community reference

Special:RecentChanges

Change log·7,183 revisions·page 46 of 72

Every change to PeptidePedia Wiki, newest first. N marks a new page, m a minor edit and b an edit by an approved bot. The byte figure is the page size after the edit; the coloured figure is the change. 7,183 changes are logged in total.

7,183Logged changes
598Bot edits
175Page creations
256Active editors

14 April 2025

  1. (diff | hist) m b 12:02 Trifluoroacetate counterion 3,899 ±0 ArchiveBot (talk | contribs) bot: normalise unit spacing [rollback]
  2. (diff | hist) 11:50 Talk:Wuhan Wansheng Biotechnology 1,666 +396 RfC_Rasmus (talk | contribs) /* RfC: what does a large report set actually support? */ reply
  3. (diff | hist) 10:38 Talk:Blind sampling 537 +216 TallySheetTad (talk | contribs) /* Selection on the outcome is a third failure, not a footnote */ new section
  4. (diff | hist) 01:13 Limit of detection 3,971 ±0 MelanocortinMil (talk | contribs) expand §Practical consequences [rollback]

13 April 2025

  1. (diff | hist) m 23:14 Customs seizure 3,644 +497 LabelLibby (talk | contribs) fix the anchor on an internal link [rollback]
  2. (diff | hist) m 22:40 Sarcopenia 3,440 ±0 A1c_Alder (talk | contribs) expand §Relevance to weight reduction [rollback]
  3. (diff | hist) 20:03 Peptide aggregation 4,377 ±0 PeakShapePol (talk | contribs) add the forced-degradation conditions the claim rests on [rollback]
  4. (diff | hist) m 12:23 WuXi TIDES 10,671 +485 EndotoxinEd (talk | contribs) add the note that self-published material is usable only for what it states about itself [rollback]
  5. (diff | hist) m 07:05 Fmoc chemistry 4,430 +18 FreightFenna (talk | contribs) give the vial sizes in millilitres of nominal capacity [rollback]
  6. (diff | hist) m b 06:24 Dulaglutide 4,161 ±0 StubSorterBot (talk | contribs) bot: expand DOI to full citation [rollback]
  7. (diff | hist) 04:00 Peptide 4,971 +38 SupplyWatchSuri (talk | contribs) expand §Nomenclature and notation [rollback]
  8. (diff | hist) 02:18 C-peptide 3,458 ±0 DEXA_Dilys (talk | contribs) add the interference the assay is known to be subject to [rollback]
  9. (diff | hist) 02:15 Underfilling 3,432 +34 SurvodutideSaff (talk | contribs) add the note on how to request a batch record rather than a certificate [rollback]

12 April 2025

  1. (diff | hist) m b 23:01 Growth hormone secretagogue 3,620 +44 CiteBot (talk | contribs) bot: flag bare reference [rollback]
  2. (diff | hist) 22:48 Loss on drying 3,735 ±0 SVG_Solomon (talk | contribs) add the plate-count expression and define its terms [rollback]
  3. (diff | hist) 22:32 Adverse effects of GLP-1 receptor agonists 5,297 ±0 SchemaSorcha (talk | contribs) alphabetise the see-also list [rollback]
  4. (diff | hist) 16:56 Deamidation 4,219 ±0 TrialsTabitha (talk | contribs) add the ionisation mode to the mass-spectrometry description [rollback]
  5. (diff | hist) m 15:36 USP General Chapter 85 4,270 ±0 ColumnOvenCoy (talk | contribs) fix a broken wikilink [rollback]
  6. (diff | hist) 15:34 Exenatide 4,449 +161 OrforglipronOona (talk | contribs) expand §The extended-release formulation [rollback]
  7. (diff | hist) 09:49 Flourishglobal Peptide Biotech 5,367 +686 BUD_Bertram (talk | contribs) move a stray full stop inside the reference [rollback]
  8. (diff | hist) 07:38 Contract development and manufacturing organisation 3,804 ±0 StopperingSteff (talk | contribs) rm the vendor-specific packaging detail; not general enough for the article [rollback]
  9. (diff | hist) m 04:47 List of GLP-1 receptor agonists 3,023 ±0 PriorAuthPaz (talk | contribs) split the list at the point where the subject changes [rollback]
  10. (diff | hist) 01:37 Xi'an Mokemei Biotechnology 3,070 +696 KarlFischerKit (talk | contribs) correct the trading name — the short code and the legal name are different things [rollback]
  11. (diff | hist) 00:16 FLOW trial 3,481 +25 EndpointEnid (talk | contribs) give the absolute risk difference alongside the relative one [rollback]

11 April 2025

  1. (diff | hist) 23:18 Prior authorisation 3,094 ±0 TitrationTheo (talk | contribs) de-duplicate a repeated sentence [rollback]
  2. (diff | hist) 22:08 Regulatory status by jurisdiction 3,391 ±0 FiveOhThreeB (talk | contribs) state that the position differs between jurisdictions and give two examples [rollback]
  3. (diff | hist) m 19:42 TRIUMPH trial programme 4,014 ±0 DrTitration (talk | contribs) the percentage quoted was placebo-adjusted; label it [rollback]
  4. (diff | hist) 10:40 Hubei Jianxiang Bioscience 2,173 +450 BlankVialBo (talk | contribs) add the note that self-published material is usable only for what it states about itself [rollback]
  5. (diff | hist) 10:05 Blind sampling 6,780 ±0 SecondarySrc_Seb (talk | contribs) add category for certificates of analysis [rollback]
  6. (diff | hist) 09:33 Talk:Wuhan Wansheng Biotechnology 1,455 +402 VerifyFirstVida (talk | contribs) /* RfC: what does a large report set actually support? */ reply
  7. (diff | hist) m b 03:34 Semaglutide 8,079 ±0 ArchiveBot (talk | contribs) bot: expand DOI to full citation [rollback]
  8. (diff | hist) m 03:31 Sterile water for injection 3,619 ±0 AnalyticalAnnie (talk | contribs) add the dead-space volume to the worked example [rollback]

10 April 2025

  1. (diff | hist) m 19:09 Cold-chain freight 3,699 ±0 RedirectRini (talk | contribs) expand §How much it matters for a lyophilised peptide [rollback]
  2. (diff | hist) 18:11 Subcutaneous injection 4,039 ±0 SortKeySascha (talk | contribs) correct the needle gauge given for subcutaneous administration [rollback]
  3. (diff | hist) 17:34 GLP-1 receptor agonist 9,254 ±0 AxisLabelAgda (talk | contribs) split §Pharmacology into receptor binding and downstream signalling [rollback]
  4. (diff | hist) 17:24 Injection site rotation 4,064 +167 EscalationEira (talk | contribs) state that swirling rather than shaking is the handling convention, sourced [rollback]
  5. (diff | hist) 10:04 Talk:Wuhan Wansheng Biotechnology 1,244 +217 PuffRemoverPax (talk | contribs) /* RfC: what does a large report set actually support? */ reply
  6. (diff | hist) 09:14 Talk:Cold chain 1,170 +94 PlainNumbersPip (talk | contribs) /* Mean kinetic temperature: the worked example */ reply
  7. (diff | hist) m 08:30 Body composition assessment 4,384 +220 PanelPlannerPam (talk | contribs) convert a hard-coded date to the house format [rollback]
  8. (diff | hist) 04:13 Peptide supply chain 6,954 +894 Hedgerow_Hal (talk | contribs) give the closure integrity test by name [rollback]

9 April 2025

  1. (diff | hist) m 23:54 Shanghai Wibson Biotechnology 6,383 +722 LotTraceLuka (talk | contribs) attribute the capability claim to the organisation's own material [rollback]
  2. (diff | hist) 22:31 Hunan Aslsen Technology 9,004 +519 SecondarySrc_Seb (talk | contribs) expand §Reception [rollback]
  3. (diff | hist) 21:55 Residual solvent 4,125 ±0 SigFigSindri (talk | contribs) move a stray full stop inside the reference [rollback]
  4. (diff | hist) 20:23 Glucagon 5,754 ±0 BPC_Bramwell (talk | contribs) sentence case in headings per PP:MOS [rollback]
  5. (diff | hist) 20:22 CagriSema 4,167 +280 ImageReuseIris (talk | contribs) add the year of first marketing authorisation, with the regulator named [rollback]
  6. (diff | hist) 16:15 VendorInvestigate 4,188 ±0 AnalyticalAnnie (talk | contribs) add the note that a purity figure without water and counterion is not a mass [rollback]
  7. (diff | hist) 15:47 Purity claim inflation 4,595 ±0 BlindSampleBrid (talk | contribs) state the date range the submitted set covers [rollback]
  8. (diff | hist) m 14:30 PeptideMeter 3,873 ±0 TallySheetTad (talk | contribs) add the difference between a batch certificate and a lot-specific one [rollback]
  9. (diff | hist) 14:01 Cagrilintide 3,187 ±0 CuriousCallum (talk | contribs) state the substitution in one-letter code as well, per PP:MOS [rollback]
  10. (diff | hist) 11:27 Talk:Wuhan Wansheng Biotechnology 1,033 +261 NPOV_Nadia (talk | contribs) /* RfC: what does a large report set actually support? */ reply
  11. (diff | hist) 10:29 Certificate of analysis 7,513 +541 PancreasPru (talk | contribs) state that the sample was not drawn blind, so it represents the vial and not the lot [rollback]
  12. (diff | hist) m 09:08 Sangon Biotech 6,911 +144 UnderfillUna (talk | contribs) expand §Notability and coverage [rollback]
  13. (diff | hist) 08:55 Talk:Cold chain 959 +284 SigFigSindri (talk | contribs) /* Mean kinetic temperature: the worked example */ reply
  14. (diff | hist) 08:41 Talk:Wuhan Wansheng Biotechnology 822 +236 TallySheetTad (talk | contribs) /* RfC: what does a large report set actually support? */ reply
  15. (diff | hist) m b 07:28 Liraglutide 5,250 +718 CategoryBot (talk | contribs) bot: expand DOI to full citation [rollback]
  16. (diff | hist) 07:07 Multi-dose vial 11,251 +853 LeanMassLars (talk | contribs) expand §Reconstituted peptides and multiple withdrawal [rollback]

8 April 2025

  1. (diff | hist) m 23:46 Dose escalation schedule 4,073 +423 CarryOverCai (talk | contribs) state the number of doses a vial yields at that concentration [rollback]
  2. (diff | hist) 21:27 Insulin syringe unit conversion 4,444 +780 ReceptorRhoda (talk | contribs) add the note that vial overfill is not assumed [rollback]
  3. (diff | hist) m 21:20 Survodutide 4,470 ±0 SemaglutideSasha (talk | contribs) add the year of first marketing authorisation, with the regulator named [rollback]
  4. (diff | hist) 21:13 Arcuate nucleus 4,321 ±0 RetatrutideRuben (talk | contribs) attribute the receptor-density claim to the tissue study it comes from [rollback]
  5. (diff | hist) 20:46 Karl Fischer titration 7,209 +164 AnalyticalAnnie (talk | contribs) expand §Relationship to other methods [rollback]
  6. (diff | hist) 14:03 Talk:Cold chain 748 +362 ColdChainCleo (talk | contribs) /* Mean kinetic temperature: the worked example */ reply
  7. (diff | hist) 14:02 Talk:Wuhan Wansheng Biotechnology 611 +338 AnalyticalAnnie (talk | contribs) /* RfC: what does a large report set actually support? */ reply
  8. (diff | hist) 11:19 Talk:Cold chain 537 +235 PlainNumbersPip (talk | contribs) /* Mean kinetic temperature: the worked example */ new section
  9. (diff | hist) 09:15 Talk:Wuhan Wansheng Biotechnology 400 +414 RfC_Rasmus (talk | contribs) /* RfC: what does a large report set actually support? */ new section
  10. (diff | hist) N 09:00 Hubei Jianxiang Bioscience 1,723 +1,723 SortKeySascha (talk | contribs) create organisation article per PP:VN
  11. (diff | hist) 06:49 Guangzhou JEEP Biotechnology 11,389 +1,387 StudentSindhu (talk | contribs) add the reception tally with its period and count stated [rollback]
  12. (diff | hist) 00:34 Test report forgery 4,203 +65 PioneerPerdita (talk | contribs) unpipe a link that did not need piping [rollback]

7 April 2025

  1. (diff | hist) 11:03 STEP trial programme 4,357 ±0 PreregPriya (talk | contribs) add the year of publication to each trial in the list [rollback]
  2. (diff | hist) 10:14 Vial filling and stoppering 4,012 +256 SPPS_Sorrel (talk | contribs) expand §Stoppering and seal integrity [rollback]
  3. (diff | hist) 09:57 Electrospray ionisation 3,512 +34 Peptide_Pete (talk | contribs) state the titration endpoint and the reagent factor [rollback]
  4. (diff | hist) 09:38 Prescribing information 3,683 ±0 LurkerLevi (talk | contribs) add the note that price is not a proxy for quality [rollback]
  5. (diff | hist) m 07:42 Proglucagon 5,743 +18 IpamorelinIsold (talk | contribs) attribute the receptor-density claim to the tissue study it comes from [rollback]
  6. (diff | hist) m b 03:10 Reverse-phase HPLC 4,282 +36 CiteBot (talk | contribs) bot: repair redlinked category [rollback]
  7. (diff | hist) m 02:43 Peptide stability table 4,018 +104 SurmountSurma (talk | contribs) expand §The table [rollback]

6 April 2025

  1. (diff | hist) m 22:17 Wuhan Wansheng Biotechnology 10,253 ±0 ChainCustodyChad (talk | contribs) add the note that this wiki publishes no score and no league table [rollback]
  2. (diff | hist) m 19:20 Gastric emptying 4,636 ±0 Chromatokid (talk | contribs) add the reference range with the assay it was established on [rollback]
  3. (diff | hist) 18:22 Hypoglycaemia 3,743 ±0 RetinopathyRex (talk | contribs) give the incidence with its denominator [rollback]
  4. (diff | hist) 17:16 Insulin secretion 5,442 ±0 ProglucagonPia (talk | contribs) alphabetise the see-also list [rollback]
  5. (diff | hist) 15:23 Bachem Holding (Suzhou) 9,744 +751 BlindSampleBrid (talk | contribs) add the outbound storefront link, marked nofollow and sponsored per the external-links convention [rollback]
  6. (diff | hist) m b 10:33 Nantong Guangyuan Chemical 9,618 ±0 ArchiveBot (talk | contribs) bot: update parent category chain [rollback]
  7. (diff | hist) 08:57 Retatrutide 5,870 +170 ApoB_Aurelio (talk | contribs) add see also to the amylin analogue [rollback]
  8. (diff | hist) 06:41 Bacteriostatic water 4,348 +524 SupplyWatchSuri (talk | contribs) give the concentration in mg/mL as well as in units [rollback]
  9. (diff | hist) m 05:13 Medutest 3,795 ±0 NPOV_Nadia (talk | contribs) split §What a report shows from §What it does not [rollback]
  10. (diff | hist) 03:34 Peptide harm reduction 3,438 +118 ParentCatPansy (talk | contribs) fix a broken wikilink [rollback]
  11. (diff | hist) m 01:19 Timeline of incretin therapeutics 3,954 +803 DiffWatchDov (talk | contribs) add the molecular formula to the infobox [rollback]

5 April 2025

  1. (diff | hist) m 18:01 Fasting insulin 3,216 +254 GsCouplingGil (talk | contribs) add category for laboratory medicine [rollback]
  2. (diff | hist) 15:30 Melanotan II 3,650 +259 ThymosinTamsin (talk | contribs) give the counterion, since it changes the mass by several per cent [rollback]
  3. (diff | hist) 14:26 Trial data comparison 4,023 +806 INN_Ingrid (talk | contribs) add the citation for the stability figures taken from the labelling [rollback]
  4. (diff | hist) m 13:53 Custom peptide synthesis 3,777 ±0 ColdChainCleo (talk | contribs) add the note that lyophilised material tolerates excursions better than solution [rollback]
  5. (diff | hist) 11:57 Cold chain 20,418 +196 CounterfeitCato (talk | contribs) state that overlay gas is used and name it [rollback]
  6. (diff | hist) 11:48 Reference standard 4,154 +34 ChromCleanupCass (talk | contribs) add the reference standard and its traceability [rollback]
  7. (diff | hist) 08:29 ChinaPeptides 7,367 +80 API_Aurora (talk | contribs) fix the anchor on an internal link [rollback]
  8. (diff | hist) 06:55 Aspiration risk under anaesthesia 3,880 ±0 MolarMassMaeve (talk | contribs) add the discontinuation rate attributable to this effect [rollback]
  9. (diff | hist) 02:16 Cost per milligram 3,001 +854 TirzTaxonomist (talk | contribs) correct the deductible description [rollback]
  10. (diff | hist) 00:28 Preparative HPLC purification 3,866 ±0 DiffWatchDov (talk | contribs) British spelling per PP:MOS [rollback]

4 April 2025

  1. (diff | hist) m 21:04 Peptide content 6,898 +351 LeanMassLars (talk | contribs) add the figure for the chromatogram and caption its axes [rollback]
  2. (diff | hist) m 20:29 Repackaging 3,958 ±0 Chromatokid (talk | contribs) add the collapse-temperature point, sourced [rollback]
  3. (diff | hist) 12:32 Placebo-adjusted effect 3,893 +222 AxisLabelAgda (talk | contribs) state the non-inferiority margin, since the design was non-inferiority [rollback]
  4. (diff | hist) 09:31 Talk:Shanghai Wibson Biotechnology 959 +180 StyleSheetSybil (talk | contribs) /* A shorter registry history is not a finding */ reply